Contineum Therapeutics, Inc. (CTNM) has 7 open-market insider trades by 3 insiders since 2026. The most active filer is Daniel S. Lorrain, CSO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Daniel S. Lorrain | CSO | — | 4 | $238K | 2026-07-09 |
| Carmine N. Stengone | CEOPres | — | 1 | $114K | 2026-09-08 |
| Tim Watkins | CMO | — | 2 | $105K | 2026-06-30 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Carmine N. Stengone | CEO & President | Sell | $41K | 2026-09-08 |
| Carmine N. Stengone | CEO & President | Sell | $40K | 2026-08-03 |
| Daniel S. Lorrain | CSO | Sell | $17K | 2026-07-08 |
| Carmine N. Stengone | CEO & President | Sell | $40K | 2026-07-08 |
| Tim Watkins | CMO | Sell | $174K | 2026-06-30 |
| Daniel S. Lorrain | CSO | Sell | $595K |
Companies that share insiders with CTNM, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2026-06-30 |
| Carmine N. Stengone | CEO & President | Sell | $160K | 2026-06-30 |
| Daniel S. Lorrain | CSO | Sell | $55K | 2026-06-01 |
| Daniel S. Lorrain | CSO | Sell | $55K | 2026-05-01 |
| Daniel S. Lorrain | CSO | Sell | $56K | 2026-04-06 |
| Tim Watkins | CMO | Sell | $54K | 2026-03-02 |
| Daniel S. Lorrain | Chief Scientific Officer | Sell | $63K | 2026-03-02 |
| Daniel S. Lorrain | CSO | Sell | $130K | 2026-02-24 |
| Carmine N. Stengone | CEO & President | Sell | $114K | 2026-02-24 |
| Daniel S. Lorrain | CSO | Sell | $2K | 2026-02-19 |